Limitations in Clinical Translation of Nanoparticle-Based Gene Therapy.
Author(s)
Type
Journal Article
Abstract
Organic nanoparticle-based (ONP) gene therapy is a potential strategy to cure human cancer. However, there are still many practical barriers before the promising results from in vitro and preclinical studies can be translated to clinical success. We discuss the reasons behind the hesitant uptake by the clinic.
Date Issued
2017-08-16
Date Acceptance
2017-07-24
Citation
Trends in Biotechnology, 2017, 35 (12), pp.1124-1125
ISSN
0167-7799
Publisher
Elsevier
Start Page
1124
End Page
1125
Journal / Book Title
Trends in Biotechnology
Volume
35
Issue
12
Copyright Statement
© 2017, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/
Identifier
PII: S0167-7799(17)30189-0
Subjects
clinical trials
gene therapy
limitations
organic nanoparticle
Publication Status
Published